Loading
companiesCompany
Nucleo
Nucleo builds AI agents that help oncologists and radiologists pull measurements and insights out of CT scans to characterise tumours and guide treatment.
Overview
Nucleo describes itself as the first agentic platform for oncology: software agents that analyse CT scans to support tumour characterisation, measurement and treatment decisions for oncologists and radiologists. The company states that it works with Stanford Hospital, Cedars-Sinai, UCI Health and Weill Cornell. It is a Fall 2025 YC company with a two-person team; its YC profile gives no headquarters city, so only the country is recorded. Regulatory status and validation data have not been published.
Headquarters
United States, US
Funding
All startupsStartupYC F25
Investors
Type
Stage
Startup · Y Combinator Fall 2025
Website
Similar pages
- CompanyAluna
Shares Y Combinator and the tag yc.
- CompanyMednet (theMednet)
Shares Y Combinator and the tag yc.
- CompanyAlixia
Shares Y Combinator and the tag yc.
- CompanyVelorum Therapeutics
Shares Y Combinator and the tag yc.
- CompanyDelee
Shares Y Combinator and the tag yc.
- CompanyiSono Health
Shares Y Combinator, AI in radiology and the tag yc.
- CompanyResistanceBio (Viosera Therapeutics)
Shares Y Combinator and the tag yc.
- CompanySerinus Biosciences
Shares Y Combinator and the tag yc.